Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

AZN US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

AZN US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Astrazeneca Plc(AZN US)

Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings
Categorized

Astrazeneca Plc(AZN US)

Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings
Categorized
Chronological
By Owner

Financials & Metrics

FinancialsChartingShort InterestEmployees
Chronological
By Owner

Financials & Metrics

FinancialsChartingShort InterestEmployees

Chronological SEC Filings

Chronological SEC Filings

Non-Ownership Filings(1.9K)

Expand
  • 6-KADMISSION OF FURTHER SECURITIES TO TRADING2 Nov
  • 6-KTOTAL VOTING RIGHTS2 Nov
  • 6-K3RD QUARTER RESULTS30 Oct
  • 6-KENHERTU APPROVED IN EU FOR HER2-POSITIVE EBC27 Oct
  • 6-KULTOMIRIS APPROVED IN US IN IGAN22 Oct
  • 6-KASTRAZENECA COMPLETES EQUITY INVESTMENT IN SUMMIT5 Oct
  • 6-KAZ & DS COLLABORATION WITH SUMMIT FOR DATROWAY2 Oct
  • 6-KADMISSION OF FURTHER SECURITIES TO TRADING1 Oct
  • 6-KTOTAL VOTING RIGHTS1 Oct
  • 6-KASTRAZENECA ANNOUNCES EQUITY INVESTMENT IN SUMMIT29 Sep
  • 6-KTRIXEO APPROVED IN EU FOR ASTHMA23 Sep
  • 6-KKLYGEFA RECOMMENDED FOR EU APPROVAL BY CHMP21 Sep
  • 6-KENHERTU RECOMMENDED FOR APPROVAL IN EU IN EARLY BC21 Sep
  • 6-KDIRECTOR/PDMR SHAREHOLDING18 Sep
  • 6-KDIRECTOR/PDMR SHAREHOLDING15 Sep
  • 6-KDIRECTOR/PDMR SHAREHOLDING15 Sep
  • 6-KUPDATE ON SERENA-4 PHASE III TRIAL14 Sep
  • 6-KIMFINZI+IMDELLTRA IMPROVED OS IN SMALL CELL LUNG8 Sep
  • 6-KETCAMAH APPROVED IN THE US FOR HR+ BREAST CANCER8 Sep
  • 6-KADMISSION OF FURTHER SECURITIES TO TRADING1 Sep

Ownership Filings(131)

Expand
  • Form 4Sharma Mani10 Nov
  • Form 4Sharma Mani8 Oct
  • Form 4Sharma Mani11 Sep
  • Form 4Sharma Mani7 Aug
  • Form 4Sharma Mani8 Jul
  • 11-KAnnual report (employee stock purchase/savings/profit sharing plans)29 Jun
  • Form 4Sharma Mani16 Jun
  • Form 4Sharma Mani22 May
  • Form 4Sharma Mani8 May
  • SC 13GASTRAZENECA PLC28 Apr
  • Form 3Sharma Mani19 Mar
  • SC 13G/AMonopar Therapeutics6 Feb
  • SC 13D/AInnate Pharma SA6 Feb
  • Form 144SARIN ARADHANA12 Nov 2025
  • 11-KAnnual report (employee stock purchase/savings/profit sharing plans)26 Jun 2025
  • SC 13G/AASTRAZENECA PLC23 Apr 2025
  • SC 13G/ACONDUIT PHARMACEUTICALS INC.10 Apr 2025
  • SC 13D/ACellectis S.A.24 Jan 2025
  • SC 13GMonopar Therapeutics28 Oct 2024
  • SC 13GCONDUIT PHARMACEUTICALS INC.11 Oct 2024

Non-Ownership Filings(1.9K)

Expand
  • 6-KADMISSION OF FURTHER SECURITIES TO TRADING2 Nov
  • 6-KTOTAL VOTING RIGHTS2 Nov
  • 6-K3RD QUARTER RESULTS30 Oct
  • 6-KENHERTU APPROVED IN EU FOR HER2-POSITIVE EBC27 Oct
  • 6-KULTOMIRIS APPROVED IN US IN IGAN22 Oct
  • 6-KASTRAZENECA COMPLETES EQUITY INVESTMENT IN SUMMIT5 Oct
  • 6-KAZ & DS COLLABORATION WITH SUMMIT FOR DATROWAY2 Oct
  • 6-KADMISSION OF FURTHER SECURITIES TO TRADING1 Oct
  • 6-KTOTAL VOTING RIGHTS1 Oct
  • 6-KASTRAZENECA ANNOUNCES EQUITY INVESTMENT IN SUMMIT29 Sep
  • 6-KTRIXEO APPROVED IN EU FOR ASTHMA23 Sep
  • 6-KKLYGEFA RECOMMENDED FOR EU APPROVAL BY CHMP21 Sep
  • 6-KENHERTU RECOMMENDED FOR APPROVAL IN EU IN EARLY BC21 Sep
  • 6-KDIRECTOR/PDMR SHAREHOLDING18 Sep
  • 6-KDIRECTOR/PDMR SHAREHOLDING15 Sep
  • 6-KDIRECTOR/PDMR SHAREHOLDING15 Sep
  • 6-KUPDATE ON SERENA-4 PHASE III TRIAL14 Sep
  • 6-KIMFINZI+IMDELLTRA IMPROVED OS IN SMALL CELL LUNG8 Sep
  • 6-KETCAMAH APPROVED IN THE US FOR HR+ BREAST CANCER8 Sep
  • 6-KADMISSION OF FURTHER SECURITIES TO TRADING1 Sep

Ownership Filings(131)

Expand
  • Form 4Sharma Mani10 Nov
  • Form 4Sharma Mani8 Oct
  • Form 4Sharma Mani11 Sep
  • Form 4Sharma Mani7 Aug
  • Form 4Sharma Mani8 Jul
  • 11-KAnnual report (employee stock purchase/savings/profit sharing plans)29 Jun
  • Form 4Sharma Mani16 Jun
  • Form 4Sharma Mani22 May
  • Form 4Sharma Mani8 May
  • SC 13GASTRAZENECA PLC28 Apr
  • Form 3Sharma Mani19 Mar
  • SC 13G/AMonopar Therapeutics6 Feb
  • SC 13D/AInnate Pharma SA6 Feb
  • Form 144SARIN ARADHANA12 Nov 2025
  • 11-KAnnual report (employee stock purchase/savings/profit sharing plans)26 Jun 2025
  • SC 13G/AASTRAZENECA PLC23 Apr 2025
  • SC 13G/ACONDUIT PHARMACEUTICALS INC.10 Apr 2025
  • SC 13D/ACellectis S.A.24 Jan 2025
  • SC 13GMonopar Therapeutics28 Oct 2024
  • SC 13GCONDUIT PHARMACEUTICALS INC.11 Oct 2024